Vichnou Colame-Poirier

Villejuif, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Upregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomas.

Upregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomas.

Journal: Oncoimmunology
Published: July 28, 2019

T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants.

T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 30, 2019

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.

Journal: Science (New York, N.Y.)
Published: April 05, 2017

The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ.

The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ.

Journal: Oncoimmunology
Published: July 11, 2016

The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer.

The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer.

Journal: Autophagy
Published: March 17, 2016

Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate.

Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate.

Journal: Oncoimmunology
Published: February 08, 2016

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients.

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients.

Journal: Oncoimmunology
Published: November 11, 2015

Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer.

Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer.

Journal: Autophagy
Published: October 29, 2015

Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy.

Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy.

Journal: Immunity
Published: September 17, 2015

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.

Journal: Science (New York, N.Y.)
Published: July 31, 2015

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.

Journal: Immunity
Published: July 27, 2015

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy.

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy.

Journal: Oncotarget
Published: May 05, 2015
Showing 1-12 of 24

Last Updated: 09/26/2026